Alpine Immune Sciences Inc expected to post a loss of 30  cents a share - Earnings Preview

Alpine Immune Sciences

14/03/2022 11:01

* Alpine Immune Sciences Inc  ALPN.OQ   ALPN.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 16 (estimated). 
    * The Seattle Washington-based  company is expected to
report  a
147.6% increase in revenue to $13.969 million from $5.64 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alpine Immune
Sciences
Inc is for a loss of 30 cents per share. For the same quarter
last year, the company reported a loss of 27 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $21​, above​ its last closing price of $7.64.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.17        0.01       -0.55     Missed  -11,10
                                                        0
 Jun. 30 2021  -0.37       -0.40      -0.46     Missed  -16.2
 Mar. 31 2021  -0.36       -0.36      -0.45     Missed  -26.2​
 Dec. 31 2020  -0.26       -0.31      -0.27     Beat    13.4
 ​​Sep.        -0.22       -0.23      -0.28     Missed  -20.4
 30 2020                                                
 Jun. 30 2020  0.04        0.54       -0.53     Missed  -199.1
                                                        ​
 Mar. 31 2020  -0.48       -0.47      -0.30     Beat    36.2
 Dec. 31 2019              -0.58      -0.33     Beat    43.6
 This summary was machine generated March 14 at 11:01 GMT.  All
figures in US dollars  unless otherwise stated